Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 11 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact11 DOIs

Add abstracts to 10 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact10 DOIs

Deposit reference lists for 6 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact6 DOIs

DOIs for this ISSN

Showing the top 5 of 84 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	The role of pseudotype neutralization assays in understandin… (10.1093/oxfimm/iqab005)	Abstract	36.56	28
2	Naive and memory T cells TCR–HLA-binding prediction (10.1093/oxfimm/iqac001)	ORCID	27.85	12
3	Is ‘Long Covid’ similar to ‘Long SARS’? (10.1093/oxfimm/iqac002)	Abstract	27.85	12
4	Adaptive immunity to SARS-CoV-2 (10.1093/oxfimm/iqaa003)	ORCID	26.98	11
5	Peptide-specific natural killer cell receptors (10.1093/oxfimm/iqaf003)	License	19.45	5
6	<i>In-vitro</i> assessment of cutaneous… (10.1093/oxfimm/iqae003)	ORCID	7.53	1
7	Cholesterol-modifying drugs in COVID-19 (10.1093/oxfimm/iqaa001)		0.00	29
8	A new immunology forum for a new age of immunology (10.1093/oxfimm/iqaa002)	Abstract References ORCID	0.00	0
9	Innate immunology in COVID-19—a living review. Part I: viral… (10.1093/oxfimm/iqaa004)		0.00	8
10	Innate immunology in COVID-19—a living review. Part II: dysr… (10.1093/oxfimm/iqaa005)		0.00	21
11	Medawar and the immunological paradox of pregnancy: in conte… (10.1093/oxfimm/iqaa006)		0.00	20
12	T cell phenotypes in COVID-19 - a living review (10.1093/oxfimm/iqaa007)		0.00	24
13	Impact of obesity and SARS-CoV-2 infection: implications for… (10.1093/oxfimm/iqab001)		0.00	11
14	Mucosal immune responses in COVID19 - a living review (10.1093/oxfimm/iqab002)		0.00	18
15	The role and uses of antibodies in COVID-19 infections: a li… (10.1093/oxfimm/iqab003)		0.00	26
16	What can neuroimmunology teach us about the symptoms of long… (10.1093/oxfimm/iqab004)		0.00	33
17	The T-cell response to SARS-CoV-2: kinetic and quantitative… (10.1093/oxfimm/iqab006)		0.00	70
18	Vaccine responses in ageing and chronic viral infection (10.1093/oxfimm/iqab007)		0.00	7
19	T-follicular helper cells in malaria infection and roles in… (10.1093/oxfimm/iqab008)		0.00	28
20	The emerging role of group 3 innate lymphoid cells in the ne… (10.1093/oxfimm/iqab009)		0.00	11
21	Overview of approved and upcoming vaccines for SARS-CoV-2: a… (10.1093/oxfimm/iqab010)		0.00	19
22	Lymphoid stromal cells—more than just a highway to humoral i… (10.1093/oxfimm/iqab011)		0.00	21
23	Regulation of antibody responses against self and foreign an… (10.1093/oxfimm/iqab012)		0.00	7
24	Harnessing NKT cells for vaccination (10.1093/oxfimm/iqab013)		0.00	18
25	Protease inhibitor plasma concentrations associate with COVI… (10.1093/oxfimm/iqab014)		0.00	15
26	TB or not to be: what specificities and impact do antibodies… (10.1093/oxfimm/iqab015)		0.00	20
27	Neutrophilia, lymphopenia and myeloid dysfunction: a living… (10.1093/oxfimm/iqab016)		0.00	14
28	Call for emergency action to limit global temperature increa… (10.1093/oxfimm/iqab017)	Abstract ORCID	0.00	0
29	Advances in understanding the formation and fate of B-cell m… (10.1093/oxfimm/iqab018)		0.00	13
30	The past, current and future epidemiological dynamic of SARS… (10.1093/oxfimm/iqac003)		0.00	36
31	Polymer formulated self-amplifying RNA vaccine is partially… (10.1093/oxfimm/iqac004)		0.00	12
32	SARS-CoV-2 immunity and vaccine strategies in people with HI… (10.1093/oxfimm/iqac005)		0.00	23
33	Long COVID: a narrative review of the clinical aftermaths of… (10.1093/oxfimm/iqac006)		0.00	35
34	Long Covid brain fog: a neuroinflammation phenomenon? (10.1093/oxfimm/iqac007)		0.00	30
35	COP27 Climate Change Conference: urgent action needed for Af… (10.1093/oxfimm/iqac008)	Abstract ORCID	0.00	0
36	Molecular mimicry among human proteinase 3 and bacterial ant… (10.1093/oxfimm/iqac009)		0.00	3
37	Isolation of single cells from human uterus in the third tri… (10.1093/oxfimm/iqac010)		0.00	2
38	Correction to: Molecular mimicry among human proteinase 3 an… (10.1093/oxfimm/iqac011)	Abstract References ORCID	0.00	0
39	Endogenous antibody responses in REGN-COV2-treated SARS-CoV-… (10.1093/oxfimm/iqac012)		0.00	1
40	Combating the challenges of COVID-19 pandemic: Insights into… (10.1093/oxfimm/iqad001)		0.00	6
41	Autoimmunity in Long Covid and POTS (10.1093/oxfimm/iqad002)		0.00	55
42	Achieving symptom relief in patients with myalgic encephalom… (10.1093/oxfimm/iqad003)		0.00	3
43	The ageing immune system as a potential target of senolytics (10.1093/oxfimm/iqad004)		0.00	17
44	A cellular overview of immunometabolism in systemic lupus er… (10.1093/oxfimm/iqad005)		0.00	24
45	The current state and future of T-cell exhaustion research (10.1093/oxfimm/iqad006)		0.00	125
46	A targeted approach to vaccine hesitancy (10.1093/oxfimm/iqad007)		0.00	2
47	Malaria and tuberculosis co-infection—a review (10.1093/oxfimm/iqad008)		0.00	8
48	Post-acute sequelae of SARS-CoV-2 infection in health care w… (10.1093/oxfimm/iqae001)		0.00	1
49	Coronin 1-dependent cell density sensing and regulation of t… (10.1093/oxfimm/iqae002)		0.00	2
50	Early interferon lambda production is induced by double-stra… (10.1093/oxfimm/iqae004)		0.00	0